Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn
In recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of the weight-loss drug Semaglutide. Some have contended that Semaglutide will greatly reduce the nu...
Weight-Loss-Drug Stock Sting May Be Easing for Device Makers
Wall Street says insulin pump maker Insulet and Tandem Diabetes, as well as glucose-monitor maker DexCom, look ready to rise after pressure from Novo Nordisk's Wegovy and Eli Lilly.
3 Healthcare Stocks That Should Be on Every Investor's Radar This Fall
As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date (YTD) performance is the second worst only behind utilities.
2 Healthcare Stocks That Could Make You Richer
Vertex has almost no weak spots thanks to a solid core franchise and several promising programs. DexCom is helping improve the lives of diabetes patients, and the company still has lots of room to ...
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
A remarkable 30-year bull run for the Nasdaq 100 saw it gain nearly 4,000% by 2020. But, the party came to a screeching halt when the pandemic hit.
DexCom (DXCM) Launches Latest CGM Sensor ONE in France
DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.
Why DexCom Stock Dove by 5% Today
A Raymond James analyst cut his price target on the specialty medical device maker. It was the second such price target cut so far this month.
Here's Why You Should Retain DexCom (DXCM) Stock for Now
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom (DXCM) Rises 7% in One Week: What's Driving It?
DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.
With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?
We believe DexCom stock (NASDAQ: DXCM) is a better healthcare pick than Intuitive Surgical stock (NASDAQ: ISRG).
Dexcom Denies Weight Loss Drug Threat To CGM Sales - I'd Be A Little Concerned
DexCom is a major player in the continuous glucose monitoring space, with steadily growing revenues and a breakout year in 2020. DXCM's market cap valuation has reached $40 billion, leading to high...
DexCom's (DXCM) G6 CGM Connects With Omnipod 5 AID in Germany
DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.
What's Next For DexCom Stock After A 17% Fall In A Month?
DexCom stock (NASDAQ: DXCM) has seen a 17% fall in a month, compared to a 2% fall for the broader S&P500 index.
Is Trending Stock DexCom, Inc. (DXCM) a Buy Now?
Recently, Zacks.com users have been paying close attention to DexCom (DXCM). This makes it worthwhile to examine what the stock has in store.
A Bull Market Is Coming: 2 Beaten-Down Stocks to Buy and Hold
Teladoc's solid position in telemedicine, improving bottom line, and strong margins make a solid case for the stock. Tandem Diabetes Care develops cutting-edge insulin pumps for diabetes patients, ...
Related Companies